MG 113 Paclitaxel, [2-benzoyl ring-13C(U), 99 atom % 13C]-
|
(Paclitaxel-[2-benzoyl ring-13C(U), 99 atom % 13C]-) |
MORpure™ Delivered ≥ 98% pure with dated HPLC UV chromatogram
|
Solid |
Screw cap v-vial - shipped on dry ice |
Please
Inquire for Pricing |
M.W. 859.9 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MC 1446 Paclitaxel,
[benzoyloxy ring-14C(U)]- |
Click here for Typical
Certificate of Analysis |
(Paclitaxel,
[benzoyloxy ring-14C(U)]-) |
MORpure™ HPLC purified,
Delivered ≥ 98% pure with dated HPLC radiochromatogram |
Ethyl acetate solution, 100 µCi/ml |
Please
Inquire for Pricing |
> 50 mCi(1.85 GBq)/mmol |
Sealed ampoule - shipped on dry ice |
M.W. 853.91 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MC 1446M Paclitaxel,
[benzoyloxy ring-14C(U)]- |
(Paclitaxel,
[benzoyloxy ring-14C(U)]-) |
HPLC purified,
Delivered ≥ 97% pure with dated HPLC radiochromatogram |
Ethyl acetate solution, 100 µCi/ml |
Please
Inquire for Pricing |
100-250 mCi(3.7-9.25 GBq)/mmol |
Sealed ampoule - shipped on dry ice |
M.W. 853.91 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MC 1446H Paclitaxel,
[benzoyloxy ring-14C(U)]- |
(Paclitaxel,
[benzoyloxy ring-14C(U)]-) |
HPLC purified,
Delivered ≥ 97% pure with dated HPLC radiochromatogram |
Ethyl acetate solution, 100 µCi/ml |
≥ 250 mCi(9.25 GBq)/mmol |
Please
Inquire for Pricing |
Sealed ampoule - shipped on dry ice |
M.W. 853.91 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MT 2081 Paclitaxel, [13-3H]-
|
MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram
|
Ethanol solution, 1 mCi/ml |
> 10 Ci(370 GBq)/mmol |
Please
Inquire for Pricing |
NextGen V-Vial - shipped on dry ice |
M.W. 853.91
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MT 1646 Paclitaxel, [2,6-benzamido-3H(N)]-
Click here for Typical Certificate of Analysis
|
(Paclitaxel,
[o-benzamido-3H(N)]-) |
MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram
|
Ethanol solution, 1 mCi/ml |
50 µCi (1.85
MBq) $1160 |
>
20 Ci(0.74 TBq)/mmol |
250 µCi
(9.25 MBq) $1970 |
NextGen V-Vial - shipped on dry ice |
1 mCi (37
MBq)
$3305 |
M.W. 853.91 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MT 552 Paclitaxel, [3H]-
Click here for Typical Certificate of Analysis
|
(Paclitaxel, [3H]-) |
MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram
|
3H
NMR indicates that the majority of the tritium is in the m- and p- positions
of the aromatic rings |
Ethanol solution, 0.1 mCi/ml |
50 µCi (1.85
MBq) $1160 |
> 3 Ci(111 GBq)/mmol |
250 µCi
(9.25 MBq) $1970 |
NextGen V-Vial - shipped on dry ice |
1 mCi (37
MBq) $3405 |
M.W. 853.91 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MC 2353
Paclitaxel pentadecylglutarate, [benzoyloxy ring-14C(U)]- |
Click
here for Typical
Certificate of Analysis |
HPLC purified,
Delivered ≥ 97% pure with dated HPLC radiochromatogram |
Ethanol
solution under argon, 25 µCi/ml |
≥ 50 mCi(1.85 GBq)/mmol |
Please
Inquire for Pricing |
NextGen V-Vial - shipped on dry ice |
M.W. 1178.40 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |